Suzuken Co Ltd represents values of trust, integrity, and innovation. The company's corporate philosophy is focused on contributing to society through its healthcare business. Suzuken Co Ltd strives to provide high-quality products and services that improve the well-being and health of individuals. With a strong commitment to ethical business practices, Suzuken Co Ltd continually seeks to meet the evolving needs of customers and stakeholders, fostering long-term partnerships built on reliability and excellence. Through its dedication to advancing healthcare solutions, Suzuken Co Ltd aims to create a healthier and more prosperous future for all.

Suzuken Co Ltd is primarily present in Japan.

Suzuken Co Ltd, a leading stock, has achieved several significant milestones over the years. One milestone is its successful expansion into the global market, establishing a strong presence in various countries. Suzuken has also demonstrated consistent growth through strategic partnerships and mergers, enhancing its product portfolio and market position. Moreover, the company has received recognition for its commitment to innovation and quality, earning prestigious industry awards. Suzuken's consistent financial performance and ability to adapt to evolving market trends further highlight its success as a trusted player in the stock industry. As a result, Suzuken Co Ltd continues to secure its position as a market leader, driving value and growth for its shareholders.

Suzuken Co Ltd is a renowned Japanese company with a rich history and background. Established in 1921, Suzuken initially operated as a wholesale distributor for pharmaceutical products. Over the years, the company expanded its operations and diversified its portfolio. Today, Suzuken Co Ltd is a leading provider of comprehensive healthcare services, including pharmaceutical distribution, home healthcare, clinical diagnostics, and healthcare IT solutions. The company's commitment to innovation and customer-centric approach has propelled its growth and reputation in the industry. With a strong presence in Japan and expanding globally, Suzuken Co Ltd continues to play a crucial role in shaping the future of healthcare delivery.

The main competitors of Suzuken Co Ltd in the market include McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These companies are global pharmaceutical wholesale distributors that operate in a similar industry as Suzuken. McKesson Corporation, based in the United States, is one of the largest healthcare services and information technology companies. AmerisourceBergen Corporation, also based in the United States, is a leading provider of pharmaceutical distribution and related healthcare services. Cardinal Health Inc. is another prominent player in the healthcare services and products sector, with operations in over 60 countries.

Suzuken Co Ltd is primarily active in the pharmaceutical industry.

The business model of Suzuken Co Ltd revolves around the distribution and sales of pharmaceutical and medical products in Japan. As a leading company in the healthcare industry, Suzuken operates through various segments including Pharmaceutical Wholesale, Pharmacy Chain, Medical Instruments and Equipment, and Home Healthcare. Suzuken collaborates with manufacturers to procure and distribute a wide range of pharmaceutical products to hospitals, clinics, and pharmacies across Japan. The company aims to enhance healthcare accessibility by providing high-quality medical supplies and services to customers. Suzuken's comprehensive business model enables it to contribute effectively to the healthcare system and meet the evolving needs of the Japanese market.

Suzuken Co KGV ir 15,02.

Suzuken Co KUV ir 0,18.

AlleAktien kvalitātes vērtējums Suzuken Co ir 4/10.

Suzuken Co apgrozījums ir 2,39 Bio. JPY.

Suzuken Co peļņa ir 29,02 miljardi JPY.

Suzuken Co Ltd is a Japanese company specializing in the sale and distribution of pharmaceuticals, medical devices, and diagnostic tests. The company was founded in 1934 and is headquartered in Kyoto, Japan. It operates in various segments, including pharmaceutical supply, medical device trading, diagnostic tests, and other business areas such as health and care products and the Suzuken Pharmacy chain. Suzuken has partnerships with international companies to meet the global demand for its products. It has made acquisitions and partnerships in recent years to expand its business activities and has focused on developing innovative services and technologies. Overall, Suzuken is a key player in the Japanese healthcare industry and is well-positioned to grow and expand its business in the future.

Suzuken Co izmaksā dividendes 72,00 JPY, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Suzuken Co vai uzņēmums nedod dividendes.

Suzuken Co ISIN ir JP3398000004.

Suzuken Co WKN ir 914027.

Suzuken Co simbols ir 9987.T.

Pēdējo 12 mēnešu laikā Suzuken Co maksāja dividendes 90,00 JPY apmērā. Tas atbilst aptuveni 1,67 % dividendes ražībai. Nākamajos 12 mēnešos Suzuken Co plāno maksāt dividendes 91,58 JPY apmērā.

Suzuken Co pašreizējā dividendu rentabilitāte ir 1,67 %.

Suzuken Co maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos oktobris, aprīlis, oktobris, aprīlis.

Suzuken Co pēdējo 23 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 91,58 JPY. Tas atbilst dividendes ražībai 1,70 %.

Suzuken Co tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Suzuken Co apmērā 50 JPY, kas tika izmaksāta 1.12.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 27.09.2024..

Pēdējās dividendes izmaksa notika 1.12.2024..

Gadā 2023, Suzuken Co izmaksāja 76 JPY dividendes.

Suzuken Co dividendes tiek izmaksātas JPY.